Month: August 2020

AB „Ignitis grupė“ (toliau – Bendrovė, „Ignitis grupė“), juridinio asmens kodas: 301844044, registruotos buveinės adresas: Žvejų g. 14, Vilnius. Bendra AB „Ignitis grupė“ išleistų obligacijų nominali vertė 900 000 000 EUR; ISIN kodai: XS1646530565; XS1853999313; XS2177349912.Bendrovė informuoja, kad 2020 m. rugpjūčio 17 d. baigė privalomą dukterinės bendrovės AB „Ignitis gamyba“ (toliau – GEN) akcijų išpirkimą, pagal kurį už įvykdytus akcijų pardavimo sandorius atsiskaitė šiandien, rugpjūčio 19 d., t. y. antrą dieną po sandorio sudarymo.  Privalomo akcijų išpirkimo laikotarpiu nuo 2020 m. gegužės 18 d. iki 2020 m. rugpjūčio 17 d. buvo supirktos 4 859 782 (keturi milijonai aštuoni šimtai penkiasdešimt devyni tūkstančiai septyni šimtai aštuoniasdešimt dvi) GEN akcijos. Jos sudaro 0,75 proc. GEN įstatinio kapitaloPasibaigus privalomam GEN...

Schlieren/Switzerland, 18 August 2020The news release can be downloaded from the following link:AttachmentRelease

伊利诺伊州威尔美特和威斯康辛州贝洛伊特及加利福尼亚州摩根山, Aug. 19, 2020 (GLOBE NEWSWIRE) —  正在合作开发尿激酶型纤溶酶原激活物受体靶向放射科免疫疗法（RIT）用于治疗重症新冠肺炎患者的Monopar Therapeutics Inc.（纳斯达克：MNPR）（伊利诺伊州威尔美特）和NorthStar Medical Radioisotopes, LLC（威斯康辛州贝洛伊特）今天宣布，与专注于加速临床前生物产品开发的领先合同研究组织Aragen Bioscience, Inc.（加利福尼亚州摩根山）建立合作伙伴关系。Aragen将进行旨在选择主要候选uPRIT的研究，以推进至重症新冠肺炎的试验性新药开发阶段。“Aragen在这一特定领域临床前研究的专业知识将加速基于MNPR-101抗体支架对主要uPRIT的选择，以推进到临床阶段，”Monopar首席科学官Andrew Mazar博士表示。“我们很高兴在uPRIT计划的这一重要阶段与Aragen开展合作，”NorthStar高级副总裁兼首席科学官James T. Harvey博士说到， “使用严格标准来选择uPRIT候选药物以推进到试验性新药研究阶段，这是我们新冠肺炎计划的一个关键部分。”“uPRIT对于重症新冠肺炎患者具有巨大的治疗潜力，”Aragen首席执行官Axel Schleyer博士表示， “我们很高兴能与Monopar和NorthStar合作进行这项重要工作。”此次合作的目的是识别具有最佳尿激酶型纤溶酶原激活物受体结合性的uPRIT，从而能够将细胞毒性放射性同位素有选择性地运送到产生“细胞因子风暴”的异常激活免疫细胞，正是这些细胞造成了重症新冠肺炎患者的严重肺部损伤、多器官损伤和死亡。关于Monopar Therapeutics Inc.Monopar Therapeutics是一家临床阶段生物制药公司，主要专注于开发延长癌症患者寿命或提高其生活质量的专有疗法。Monopar处于不同研发阶段的产品包括：用于预防口咽癌症患者因化疗引起严重口腔黏膜炎的Validive®；用于治疗晚期软组织肉瘤的camsirubicin；以及用在晚期癌症和重症新冠肺炎的后期临床前抗体MNPR-101。如需获取更多信息，请访问：www.monopartx.com。关于NorthStar...

Fort Lauderdale, FL, Aug. 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — MediXall Group Inc. (OTCQB: MDXL), a technology and innovation-driven organization focused on reducing healthcare costs and transforming the patient-provider experience through the launch of its Health Karma™ platform, is pleased to announce the formation of their Health Insurance Advisory Board with the appointment of Don Mathern as a non-executive director. Don brings more than 45 years of comprehensive healthcare expertise and relationships from the individual and employer health insurance market segments and will provide guidance to help support and shape continuing innovation at MediXall Group. Specifically, Don will provide guidance and support on strategic initiatives as the Company accelerates business growth, expands its services, and strives...

BASKING RIDGE, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) — Verizon is now the official 5G and 4G LTE network partner of Twitch Rivals North America, a tournament series made for Twitch streamers. Together, Verizon and Twitch will collaborate on media and broadcast integrations in Twitch Rivals streams, activations at Twitch events, and innovate together using the power of Verizon’s 5G Ultra Wideband network, 5G built for gamers. Twitch and Verizon will co-create 5G concepts over the course of the partnership, exploring the impact 5G can have across the industry.“From evolving the way creators and fans watch and play, to creating new, immersive ways for the massive gaming community to connect through augmented online and in-person experiences, the combination of Twitch’s influence and the impact 5G will have on the gaming industry opens...

Finance Calendar update and notice to Extraordinary General Meeting Finance Calendar 202031th Aug 2020: Interim report Q2 202031th Aug 2020: Extraordinary General Meeting26th Nov 2020: Interim report Q3 2020Notice Extraordinary General Meeting 31th August 2020Idavang A/S CVR 30 95 61 43The agenda of the meeting of shareholdersElection of chairman for the annual meeting of shareholdersReduction of the share capital with nominally EUR 200.000 at a rate of 8.952,50 for the purpose of distribution to a shareholderAuthorisation to file the capital reduction with the Danish Business Authority

MIAMI, Aug. 19, 2020 (GLOBE NEWSWIRE) — via NetworkWire — Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), today issues the following letter to shareholders.Dear Fellow Shareholders,We hope you and your loved ones remain safe and healthy during this COVID pandemic.  We continue working diligently on the pending merger with Mullen Technologies and we have taken steps to reduce operating expenses related to our payments processing business as we go through the process contemplated by the Merger Agreement. Since announcing the contemplated merger, we have received a number of inquiries from shareholders requesting clarification regarding the expected...